ScienHub

People attending a scientific conference Test tubes in a lab tray People attending a conference

We enable the scientific community to achieve excellence

At ScienHub we offer comprehensive solutions for the implementation of clinical research and knowledge transfer. We accompany the scientific community in all phases of its specialized work, ensuring the quality and effectiveness of the results obtained.

Units

  • ScienHub
    Research Support

    Unit specialized in the management and development of clinical studies. We promote research by offering comprehensive support in the management and implementation of projects, ensuring their quality and offering maximum reliability of the results obtained.

  • ScienHub
    Education

    Unit dedicated to the dissemination and knowledge transfer in the medical and scientific field. We promote the professional growth of the scientific community by creating spaces to share and expand knowledge.

ScienHub in 2023

  • ScienHub

    Support to multiple therapeutic areas

    • Cardiology
    • Covid-19 and Long-Covid
    • Dermatology
    • Gastroenterology
    • Immunology
    • Nephrology
    • Oncology
    • Rheumatology
    • Urology
    • HIV
  • Education

    +50
    activities

    We have offered a wide variety of courses, conferences, congresses and webinars in all formats (face-to-face, hybrid and online).

  • Education

    +3.180
    attendees

    The professionals who attended our training activities in 2023 were primarily specialist doctors (27.1%), followed by primary care physicians (15.1%), and students (13.3%).

  • CRO

    60
    studies managed

    From the Contract Research Organization (CRO), we have managed 23 clinical trials, 20 research projects, 10 investigations involving medical devices, 4 cohorts, and 3 observational studies with pharmaceuticals.

  • Test tubes in a tray
  • CTU

    59
    studies implemented

    From the Clinical Trials Unit (CTU), we have implemented 59 clinical studies: 4 of them were Phase I and II, and the rest were Phase III and IV trials, as well as cohorts.

  • ScienHub in 2023

  • ScienHub

    Support to multiple therapeutic areas

    • Cardiology
    • Covid-19 and Long-Covid
    • Dermatology
    • Gastroenterology
    • Immunology
    • Nephrology
    • Oncology
    • Rheumatology
    • Urology
    • HIV
  • Education

    +50
    activities

    We have offered a wide variety of courses, conferences, congresses and webinars in all formats (face-to-face, hybrid and online).

  • Education

    +3.180
    attendees

    The professionals who attended our training activities in 2023 were primarily specialist doctors (27.1%), followed by primary care physicians (15.1%), and students (13.3%).

  • CRO

    60
    studies managed

    From the Contract Research Organization (CRO), we have managed 23 clinical trials, 20 research projects, 10 investigations involving medical devices, 4 cohorts, and 3 observational studies with pharmaceuticals.

  • Test tubes in a tray
  • CTU

    59
    studies implemented

    From the Clinical Trials Unit (CTU), we have implemented 59 clinical studies: 4 of them were Phase I and II, and the rest were Phase III and IV trials, as well as cohorts.

  • ScienHub Education launches the first training event of the Center of Excellence in Infectious Diseases

    ScienHub Education, the training platform of the Fundació Lluita contra les Infeccions, has organized the first specialized training event as part of its accreditation as a Center of Excellence in Infectious Diseases by Gilead Sciences. The event, held on February 19 and 20, 2025, brought together experts to discuss the latest advances in SARS-CoV-2 infections and immunocompromised patients.

    The program featured specialists such as Dr. Roger Paredes, Head of the Infectious Diseases Department at Hospital Germans Trias, who emphasized: “This course allows us to establish a meeting space to share knowledge on complex infections.” Dr. Lourdes Mateu and Dr. Alba Romero led key sessions on long COVID and kidney transplantation.

    This initiative strengthens ScienHub Education’s commitment to innovation and training in the field of infectious diseases.

  • "Soc Recerca brings research closer to people"

    In 2024, ScienHub launched Soc Recerca, a digital platform designed to connect volunteers with clinical studies and streamline medical research management. Anna Chamorro, Lead Study Coordinator at ScienHub Research Support, highlights its importance in advancing science and making research more accessible.

    “Soc Recerca aims to bring research closer to people and make it more interactive, where participants and scientists actively collaborate. It not only facilitates study enrollment but also provides clear information about processes and volunteer rights.”

    The platform has optimized recruitment, enabling high-demand studies to find participants quickly and efficiently. A key example was the COVID-19 vaccine trials, where Soc Recerca received 4,000 applications in a single weekend, selecting between 200 and 300 participants in record time.

    Beyond recruitment, Anna Chamorro emphasizes the effort to understand what drives or hinders participation in clinical studies:

    “We want to learn from volunteers’ experiences, understand their concerns, and improve the information provided to make research more accessible and safer for everyone.”

    With the leadership of professionals like Anna Chamorro, ScienHub reaffirms its commitment to medical innovation and informed participation in science.

    Learn more about Soc Recerca
  • Revolution 2025: Breakthroughs and Challenges in HIV with Alejandro Gaviria, Former Minister of Health of Colombia

    This February, we co-organized, together with the Fight Infections Foundation, the second edition of the Revolution conference, coordinated by Drs. Boris Revollo and Arkaitz Imaz, which brought together experts to discuss the advances and challenges in the treatment and prevention of HIV. Among the speakers was Alejandro Gaviria, former Minister of Health of Colombia, who shared his experience on the democratization of access to treatments and the financial sustainability of healthcare systems in middle and low-income countries.

    Alejandro Gaviria, who led the Ministry of Health and Social Protection of Colombia for six years, highlighted the importance of ensuring equitable access to medications and managing technological pressure, a key challenge for health equity. He also emphasized the bioethical dilemmas he faced as a minister, stressing that many of the challenges in healthcare sustainability stem from decisions on treatment financing. For him, these debates should play a central role in public discussion.

    Read the full article
  • ScienHub and Its Key Role in the SUPERNOVA Study on Preventive Monoclonal Antibodies Against COVID-19

    The SUPERNOVA study evaluates the efficacy of preventive monoclonal antibodies against SARS-CoV-2 in patients with antibody synthesis deficiencies, whether due to primary causes or secondary to biological or immunosuppressive treatments.

    ScienHub’s contribution to this study has been essential, as it was responsible for coordinating and executing all procedures, as well as conducting thorough follow-ups over the course of a year through weekly phone calls to assess the onset of COVID-19 symptoms in enrolled patients. With 30 participating patients, our center was the second most active hospital in Spain in terms of participation.

    Approval of Sipavibart

    Recently, AstraZeneca announced the approval of sipavibart (AZD3152) in Europe and Japan for the prevention of symptomatic COVID-19 in immunocompromised populations, based on the results of the SUPERNOVA study.

    These findings reinforce ScienHub’s crucial role in advancing preventive strategies for vulnerable populations and highlight the importance of clinical research in the fight against COVID-19.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop